Who We Want Analytical problem solvers. People who go beyond just fixing to identify root causes, evaluate optimal solutions, and recommend comprehensive upgrades to prevent future issues. Goal-oriented developers. Keeping the customer and requirements squarely in focus, people who deliver safe and robust solutions. Self-directed imitators. People who take ownership of their work and need …
Who We Want Analytical problem solvers. People who go beyond just fixing to identify root causes, evaluate optimal solutions, and recommend comprehensive upgrades to prevent future issues. Goal-oriented developers. Keeping the customer and requirements squarely in focus, people who deliver safe and robust solutions. Self-directed imitators. People who take ownership of their work and need …
Job Brief: The objective of the full-time position will be responsible for driving Marketing activities through regional markets. The candidate will spearhead and optimize marketing efforts and collaborate with the sales and operations teams focusing on marketing and promotion for products sold through both B2B and B2C channels to maximise marketing investments. Responsibilities: Manage …
Job Brief: You will be joining a team and culture that prides itself in its diversity, career growth and hands-on learning opportunities. You will contribute to taking HEMO’s new products from the concept stage towards production. Working collaboratively as part of a project team including but not limited to the following activities: product design and …
Assistant/Electrical & Electronics Engineer (EEE) Read More »
HEMO CHINA was present at CSA & TISC 2021, this year’s edition of the Annual Scientific Session of Chinese Stroke Association (CSA) and Tiantan International Stroke Conference (TISC). At the symposium, HEMO CHINA also marked the commercial launch of its Afentta™ and FocuStar™ products with a series of academic promotion activities.
HEMO BIOENGINEERING LIMITED (“HEMO”), a Singapore-based medical device company with a focus on treating stroke patients, is pleased to announce that its Afentta™ intracranial thrombectomy aspiration catheter – a product developed by HEMO’s branch in China – has received pre-market approval from the National Medical Products Administration (“NMPA”), becoming the first approved domestic product of …
HEMO Receives NMPA Approval for Afentta™ Aspiration Catheter Read More »
Big congratulations go to our HEMO CHINA subsidiary for being recognized as the 18th Top Medical Device Company in this year’s prestigious Future Healthcare VB100 Conference. This is a spectacular jump from a year ago when HEMO was barely known then. Big thanks also go to all our supporters, partners, stakeholders, clients and employees.
enquire@hemocorp.com
